Abstract

Human immunodeficiency virus type-1 (HIV-1) can either undergo a lytic pathway to cause productive systemic infections or enter a latent state in which the integrated provirus remains transcriptionally silent for decades. The ability to latently infect T-cells enables HIV-1 to establish persistent infections in resting memory CD4+ T-lymphocytes which become reactivated following the disruption or cessation of intensive drug therapy. The maintenance of viral latency occurs through epigenetic and non-epigenetic mechanisms. Epigenetic mechanisms of HIV latency regulation involve the deacetylation and methylation of histone proteins within nucleosome 1 (nuc-1) at the viral long terminal repeats (LTR) such that the inhibition of histone deacetyltransferase and histone lysine methyltransferase activities, respectively, reactivates HIV from latency. Non-epigenetic mechanisms involve the nuclear restriction of critical cellular transcription factors such as nuclear factor-kappa beta (NF-κB) or nuclear factor of activated T-cells (NFAT) which activate transcription from the viral LTR, limiting the nuclear levels of the viral transcription transactivator protein Tat and its cellular co-factor positive transcription elongation factor b (P-TEFb), which together regulate HIV transcriptional elongation. In this article, we review how T-cell receptor (TCR) activation efficiently induces NF-κB, NFAT, and activator protein 1 (AP-1) transcription factors through multiple signal pathways and how these factors efficiently regulate HIV LTR transcription through the non-epigenetic mechanism. We further discuss how elongation factor P-TEFb, induced through an extracellular signal-regulated kinase (ERK)-dependent mechanism, regulates HIV transcriptional elongation before new Tat is synthesized and the role of AP-1 in the modulation of HIV transcriptional elongation through functional synergy with NF-κB. Furthermore, we discuss how TCR signaling induces critical post-translational modifications of the cyclin-dependent kinase 9 (CDK9) subunit of P-TEFb which enhances interactions between P-TEFb and the viral Tat protein and the resultant enhancement of HIV transcriptional elongation.

Highlights

  • With the introduction of the highly active antiretroviral therapy (HAART), the morbidity and mortality rate among human immunodeficiency virus (HIV)-infected individuals has reduced dramatically [1]

  • The amount of latently infected cells is very limited, a highly stable pool of latently-infected cells are always present in HIV patients, which remains a barrier for human immunodeficiency virus type-1 (HIV-1) eradication in patients undergoing effective HAART therapy [12]

  • Roebuck and colleagues [69] reported that activator protein 1 (AP-1) binds to phorbol ester-responsive elements located within the 50 noncoding region of the HIV long terminal repeats (LTR) known as the downstream sequence element (DSE) located at nucleotide positions +84 to +105 and +149 to +170 to modulate Human immunodeficiency virus type-1 (HIV-1) transcription

Read more

Summary

Introduction

With the introduction of the highly active antiretroviral therapy (HAART), the morbidity and mortality rate among HIV-infected individuals has reduced dramatically [1]. The ability of HIV to establish latent infections at the level of individual T-cells remains the main barrier to eradicate HIV [7]. The most-stable reservoir of HIV resides in the transcriptionally-silent resting memory CD4+ T-cells [9,10]. In transcriptionally-inert resting memory T-cells, HIV latency is established due to the unavailability of transcription factors [11]. The amount of latently infected cells is very limited (approximately one in one million of resting T-cells), a highly stable pool of latently-infected cells are always present in HIV patients, which remains a barrier for human immunodeficiency virus type-1 (HIV-1) eradication in patients undergoing effective HAART therapy [12]. We will shed light on post-translational modifications of the cyclin-dependent kinase 9 (CDK9) subunit of positive transcription elongation factor b (P-TEFb) which enhances the interactions between P-TEFb and the viral Tat protein and the resultant enhancement of HIV transcriptional elongation

The T-Cell Receptor Signalosome
The NF-κB Transcription Factors
The NFAT Transcription Factors
Influence of TCR Activation on HIV Infection
Molecular Control of HIV Gene Expression
Role of NF-κB in HIV-1 Transcription
Role of NFAT in HIV-1 Transcription
Regulation of HIV-1 Transcription by MAPK-Activated AP-1
Role of HIV LTR Sequence Diversity on HIV Transcriptional Response
Findings
Conclusions and Prospects for
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call